From Name

From Email

To Name

To Email

Message

Novel Excipients: Gaining Traction in the Industry

from By Patricia Van Arnum — DCAT Editorial Director

Novel Excipients: Gaining Traction in the Industry By Patricia Van Arnum — DCAT Editorial Director The FDA is considering a pilot program for the toxicological and quality evaluation of novel excipients. Excipients now are not separately reviewed by the FDA, and some say a separate review mechanism would support development of new excipients and overall product innovation. READ MORE

more